Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, As Represented By”

2,152 pharma patents match "The United States of America, As Represented By" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,152
Index total 30,257
Page 20 / 90

Quick answer

This filtered view shows 2,152 pharmaceutical patents matching "The United States of America, As Represented By" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,152 results for “The United States of America, As Represented By” · 30,257 patents in full index Clear search

  1. US 10758613

    Combination therapies using anti-metabolites and agents that target tumor-associated stroma or tumor cells

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted

  2. US 10758614

    Combination therapies targeting tumor-associated stroma or tumor cells and topoisomerase

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted

  3. US 10759838

    Myelin oligodendrocyte glycoprotein, myelin basic protein, and proteolipid protein compositions and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted

  4. US 10744193

    Immunogenic RSV polypeptides

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted

  5. US 10737995

    Nuclear receptor modulators and their use for the treatment and prevention of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted

  6. US 10738313

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted

  7. US 10738047

    Iodonium analogs as inhibitors of NADPH oxidases and other flavin dehydrogenases; formulations thereof; and uses thereof

    The United States of America, as represented by the Secretary, Department of Health · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted

  8. US 10738116

    Dual specific anti-CD22-anti-CD19 chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted

  9. US 10738312

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted

  10. US 10730941

    Antigen-binding proteins targeting CD56 and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  11. US 10730835

    Thalidomide analogs and methods of use

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  12. US 10729756

    Viable viruses with foreign tags

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  13. US 10723803

    CD47 targeted therapies for the treatment of infectious disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  14. US 10723787

    Methods for alleviating symptoms of sporadic amyotrophic lateral sclerosis by neutralizing a HERV-K envelope protein using an anti-HERV-K envelope protein antibody

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  15. US 10722561

    Aquaporin 2 protects cattle from ticks and tick-borne parasites

    The United States of America, as represented by the Secretary of Agriculture · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  16. US 10716809

    Methods of producing enriched populations of tumor reactive T cells from peripheral blood

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted

  17. US 10709790

    Chemical conjugates of Evans Blue derivatives and their use in the production of long-acting therapeutics

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 14, 2020 · Expires Jul 9, 2040

    granted

  18. US 10711068

    Anti-CD133 monoclonal antibodies and related compositions and methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 14, 2020 · Expires Jul 9, 2040

    granted

  19. US 10703746

    Mutant IDH1 inhibitors useful for treating cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted

  20. US 10703816

    M971 chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted

  21. US 10696631

    Chemical conjugates of evans blue derivatives and their use as radiotherapy and imaging agents

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted

  22. US 10695355

    Methods for pharmacologic treatment of stroke

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted

  23. US 10689456

    Anti-CD70 chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted

  24. US 10683362

    Recombinant immunotoxin targeting mesothelin

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.